Dengue Vax/Zika Challenge (CIR 369)
Outpatient Study enrolling healthy adults 18-40 years old
The purpose of this study is to test the effects of the ZIKA virus against a Dengue vaccine. We hope to see if the Dengue vaccine is effective to protect individuals against the Zika virus.
The study is:
- 1 year long
- enrolling healthy adults 18-40 years old
- at least 2 screening visits
- 1 vaccination visit
- 12 follow up visits after vaccination
- 1 zika challenge visit
- 19 follow up visits after challenge
Screening Dates
September 4, 2024
September 9, 2024
September 16, 2024
September 18, 2024
Screening Location(s)
CIR Johns Hopkins East Baltimore Campus
Rangos Building
855 N. Wolfe Street Suite 601
Baltimore, MD 21205
Study Period
One year
Compensation
Up to $6100